ONESTEP SCRIBE

Psychiatric progress note example: an annotated medication management follow-up

By Selam Koch, PMHNP-BC, founder of OneStep Scribe and practicing psychiatric nurse practitioner. Published July 2026.

The progress note is the note you write ten or more times a day, and it is exactly where documentation quality quietly decays. Nobody clones an intake. Follow-up notes get cloned constantly, because visit twelve feels like visit eleven and the clock is running. A good psychiatric progress note does not need to be long. It needs to prove four things in under a page: what changed since the last visit, the patient's current mental status, that risk was assessed, and a medication decision with a rationale.

What a psychiatric progress note has to do

Whether you are a psychiatrist or a PMHNP, every follow-up note carries the same load. The initial evaluation established the diagnosis (that structure is covered in the 90791 vs 90792 evaluation guide); the progress note tracks it forward. The working checklist:

A therapist's progress note carries a related but distinct load, centered on interventions used, the patient's response, and progress toward treatment goals rather than medication decisions. Both matter; this article centers the prescriber follow-up.

The example note

The patient below is fictional. The ALL-CAPS headings are the structure OneStep Scribe actually emits for progress notes, shown here as a working template. This example uses the core sections; the full structure also includes primary stressors, substance use, goals and objectives, and a medical necessity justification.

Psychiatric follow-up note (established patient, week 6)

CHIEF COMPLAINT

"The edge is off, but I still spend the first hour of every workday dreading it." A.R. is a 28-year-old with generalized anxiety disorder presenting for follow-up. Last seen 6 weeks ago, at which time escitalopram 10 mg daily was initiated.

INTERVAL EVENTS

Since the last visit, A.R. reports partial improvement. Evening worry and sleep-onset rumination have clearly eased: "I can actually turn my brain off at night now." Morning anticipatory anxiety persists, worst before team meetings in her new project lead role. Taking escitalopram daily with no missed doses; mild nausea in the first week resolved, and she denies other side effects.

PRIMARY SYMPTOM REVIEW

Excessive worry (Improving): Reduced in the evenings but persistent in the mornings. "It used to be all day. Now it burns off by lunch."
Muscle tension (Stable): "My shoulders are still up around my ears by noon."
Insomnia (Improving): Sleep onset now under 30 minutes most nights, previously 2 hours.

Functional impact: performing well in the new role but avoids volunteering in meetings; evenings and social functioning largely recovered.

RISK ASSESSMENT

Suicidal Ideation: Denies.
Homicidal Ideation: Denies.
Protective factors: engaged in treatment, supportive partner, future-oriented about career.
Overall risk level: Low. Calm, stable presentation with denial of ideation and intact protective factors.

MENTAL STATUS EXAMINATION

Alert and engaged, mood "better, not all the way there," affect congruent with a mild anxious undertone. Thought process linear and goal directed with no perceptual disturbances. No suicidal or homicidal ideation.

DIAGNOSTIC FORMULATION

F41.1 Generalized anxiety disorder
Trajectory: Improving
Partial response at 6 weeks on escitalopram 10 mg: worry and sleep meaningfully improved, with residual morning anticipatory anxiety and muscle tension that continue to affect work functioning.

PLAN

1. Increase escitalopram to 20 mg daily. Rationale: partial response at an adequate 6-week trial of 10 mg with good tolerability; optimizing the dose is preferred over switching given the clear early benefit. Reviewed common side effects and warning signs to report.
2. GAD-7 today: 11, down from 17 at initiation. Improvement consistent with reported gains; repeat at next visit to confirm response to the higher dose.
3. Follow up in 4 weeks to assess response; patient will call sooner if symptoms worsen or side effects emerge.

What a reviewer checks here: the four proofs, each in its own section. Interval change lives in INTERVAL EVENTS, current mental status in a brief MSE that matches the history, risk in an explicit RISK ASSESSMENT, and the medication decision in a PLAN that states its rationale: partial response plus good tolerability, so increase rather than switch. The GAD-7 is interpreted against the prior score, not just listed. And the note is verifiably from this session because it carries the patient's own words. "My shoulders are still up around my ears by noon" cannot be cloned from last month's note.
How this note supports its E/M level: by medical decision making, one chronic illness with inadequate control (GAD with partial response) plus prescription drug management (a dose increase with risk discussion) supports moderate MDM, the basis of a 99214. The full logic is in the 99214 with 90833 billing guide. If you also delivered 16 or more minutes of psychotherapy in this visit, a separately documented psychotherapy add-on section belongs after the plan; see the annotated 90833 note example for exactly what that section must contain.

The five ways progress notes decay

On cloning specifically: cloned documentation is a well-recognized audit flag. Payers and their contractors run pattern analysis on billing data to select charts for review, and once a records request lands, identical language repeating across visits and across patients is one of the first things a reviewer looks for.

Do therapists need a different structure?

Yes in emphasis, no in discipline. A therapist's progress note centers the interventions used, how the patient responded, and progress toward treatment goals, rather than medication decisions. The underlying standard is identical: session-specific content, risk documented, goals tracked over time. OneStep Scribe drafts both formats.

Frequently asked questions

How long should a psychiatric progress note be?

Long enough to prove the four things: interval change, current mental status, risk, and a reasoned medication decision. For most follow-ups that is well under a page. Length is not quality, and padding a note does not make it more defensible.

Do I need a full MSE every visit?

A brief, focused MSE is standard at every visit. Full detail belongs where it is clinically indicated: new patients, significant status changes, safety concerns, or diagnostic uncertainty.

Can I copy forward my last note?

Carrying forward static history, such as past medications or family history, is common practice. But every clinical element, including interval history, MSE, risk, and plan, must be re-verified and updated at each visit. Cloned notes are a recognized audit flag.

Should scales go in every note?

When you use them, chart the score and interpret the trajectory; a raw number without context does no work. How often you administer them depends on your workflow and on any payer measurement programs you participate in.

What about time documentation?

If you bill the E/M on MDM, a time statement is optional. If you bill a psychotherapy add-on, the psychotherapy minutes must be stated separately from E/M work; the billing guide walks through the rules.

The example above is the exact structure OneStep Scribe drafts automatically.

OneStep Scribe listens to the visit and drafts progress notes, evaluations, and SOAP notes in this structure, with the patient's own words, for psychiatrists, PMHNPs, therapists, and psychologists. Every account is NPI-verified, and every note is yours to review and sign.

Start a 14-day free trial

This article is educational and reflects one clinician's documentation approach. It is not legal, billing, or payer-specific advice, and it does not guarantee reimbursement. CPT is a registered trademark of the American Medical Association. The patient described is fictional. Always verify requirements with your payers and compliance advisors.